» Articles » PMID: 23535719

Spatial Learning Impairments in PLB1Triple Knock-in Alzheimer Mice Are Task-specific and Age-dependent

Overview
Publisher Springer
Specialty Biology
Date 2013 Mar 29
PMID 23535719
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

We recently generated an advanced mouse model of Alzheimer's disease (AD) by targeted knock-in of single-copy mutated human amyloid precursor-protein (APP) and tau genes, crossed with a non-symptomatic presenilin (PS1A246E) over-expressing mouse line. These PLB1Triple mice presented with age-dependent and AD-relevant phenotypes. Homozygous PLB1Triple mice aged 4-12 months were assessed here in a battery of spatial learning tasks: Exp.1 radial-arm water maze (spatial reference and working memory) Exp.2 open-field water maze (spatial reference memory); Exp.3 home cage observation system with spatial learning (IntelliCage); Exp.4 spontaneous object recognition (SOR; novel object and spatial object shift). A separate test with high-expression transgenic APP mice matching the design of experiment 1 was also performed. Spatial deficits in PLB1Triple mice were confirmed at 12, but not 4 months in both water maze tasks. PSAPP mice, by contrast, presented with severe yet non-progressive spatial learning deficits already at 4 months. During tests of spatial learning in SOR and IntelliCage, PLB1Triple mice neither acquired the location of the water-rewarded corner, nor recognize novel or spatially shifted objects at 4 months, indicating these protocols to be more sensitive than the water maze. Collectively and in line with AD symptomatology, PLB1Triple mice present with a graded and progressive age-dependent loss of spatial memory that can be revealed by the use of a battery of tasks. With the emergence of subtle deficits progressively increasing in severity, PLB1Triple mice may offer a more patho-physiologically relevant model of dementia than aggressive expression models.

Citing Articles

IntelliCage: the development and perspectives of a mouse- and user-friendly automated behavioral test system.

Lipp H, Krackow S, Turkes E, Benner S, Endo T, Russig H Front Behav Neurosci. 2024; 17:1270538.

PMID: 38235003 PMC: 10793385. DOI: 10.3389/fnbeh.2023.1270538.


Progressive sleep disturbance in various transgenic mouse models of Alzheimer's disease.

Drew V, Wang C, Kim T Front Aging Neurosci. 2023; 15:1119810.

PMID: 37273656 PMC: 10235623. DOI: 10.3389/fnagi.2023.1119810.


IntelliCage Automated Behavioral Phenotyping Reveals Behavior Deficits in the 3xTg-AD Mouse Model of Alzheimer's Disease Associated With Brain Weight.

Winslow W, McDonough I, Tallino S, Decker A, Vural A, Velazquez R Front Aging Neurosci. 2021; 13():720214.

PMID: 34483889 PMC: 8414893. DOI: 10.3389/fnagi.2021.720214.


Early Identification of Alzheimer's Disease in Mouse Models: Application of Deep Neural Network Algorithm to Cognitive Behavioral Parameters.

Sutoko S, Masuda A, Kandori A, Sasaguri H, Saito T, Saido T iScience. 2021; 24(3):102198.

PMID: 33733064 PMC: 7937558. DOI: 10.1016/j.isci.2021.102198.


Gene therapy using Aβ variants for amyloid reduction.

Park K, Wood C, Li J, Taylor B, Oh S, Young N Mol Ther. 2021; 29(7):2294-2307.

PMID: 33647457 PMC: 8261072. DOI: 10.1016/j.ymthe.2021.02.026.


References
1.
Oddo S, Caccamo A, Kitazawa M, Tseng B, LaFerla F . Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging. 2003; 24(8):1063-70. DOI: 10.1016/j.neurobiolaging.2003.08.012. View

2.
Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E . Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res. 2012; 234(2):334-42. DOI: 10.1016/j.bbr.2012.07.004. View

3.
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S . Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996; 274(5284):99-102. DOI: 10.1126/science.274.5284.99. View

4.
Deiana S, Harrington C, Wischik C, Riedel G . Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology (Berl). 2008; 202(1-3):53-65. DOI: 10.1007/s00213-008-1394-2. View

5.
Jyoti A, Plano A, Riedel G, Platt B . EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. J Alzheimers Dis. 2010; 22(3):873-87. DOI: 10.3233/JAD-2010-100879. View